Wednesday, March 4, 2026

Eli Lilly’s Oral GLP-1 Shows 7.9% Weight Loss in Type 2 Diabetes Trial

Eli Lilly's orforglipron shows promise in Phase 3 trials for diabetes and obesity, offering an oral alternative to injectables.

Is Russia Breaking Sanctions? North Korean Clothing Ads Spark Controversy

North Korean clothing advertised on Russian TV violates UN sanctions, raising concerns about sanctions breaches and international trade.

OpenAI Loosens ChatGPT Response Restrictions Amid Censorship Criticism

OpenAI relaxed content restrictions on ChatGPT in response to ongoing censorship criticism from figures like Trump and Elon Musk.

Tag: Iran conflict

No posts to display

Top News

- Our Sponsors Ad -

Follow us